Global niche leader Family-owned global medical technology company focused on regional anesthesia, laparoscopy, biopsy and dental, offering targeted solutions that appeal to hospitals and surgical centers seeking specialized, high-quality equipment.

Innovation driven Strong engineering heritage since 1965 with clinically developed, needle and catheter systems (such as SPROTTE needle, SonoPlex needle, E-Cath/E-Cath Plus) that can be positioned as differentiators in regional anesthesia and pain management.

Opioid reduction Active involvement in opioid abuse reduction and partnerships with local communities and government agencies, presenting opportunities to align with buyers prioritizing safer, non-opioid analgesia programs.

US market focus US presence outside Atlanta with a catalog of market-leading regional anesthesia and neurology products, suggesting collaboration opportunities with U.S. hospitals, ambulatory surgical centers, and academic centers seeking proven nerve block solutions.

Growth opportunites Revenue in the low-to-mid seven figures and a scalable product line ready for expansion; potential upsell to integrated disposable tooling, procedural kits, and service contracts as facilities consolidate vendors.